Date of Issue: 09/01/2022 | Volume: 20 | Number: 9
Issue Links:Learning Objectives | Editorial Information
Students face new psychiatric problems as they return to college in the time of COVID. Low-dose lithium may prevent dementia. New therapies for antipsychotic weight gain, negative symptoms of schizophrenia, and a look at antidepressants in patients with a history of trauma.
Date of Issue: 08/01/2022 | Volume: 20 | Number: 8
Issue Links:Learning Objectives | Editorial Information
We interview Richard Brown on complementary therapies in ADHD and highlight new treatments for dyslexia and sluggish cognitive tempo. Factors that get in the way of antidepressants, and tips on dosing lithium, bupropion, olanzapine, and managing carbamazepine interactions.
IN BRIEF Alfred Kinsey caused widespread shock in 1948 when his surveys of sexual behavior revealed what was happening behind bedroom doors. This year, researchers from Kinsey’s institution (Indiana University) updated his work, and this time the surprise is about...
When patients don’t respond to an antidepressant, it’s a good idea to step back and look for anything that might be getting in the way. Major stress, substance use, medication nonadherence, anxiety, and medical and psychiatric comorbidities are high on...
Esketamine (Spravato) was approved for treatment-resistant depression in 2019. In this interview, Dr. Williams (who has no relationship with Janssen Pharmaceuticals, Inc) addresses some lingering doubts that have been raised about the medicine. TCPR: Where does esketamine fit in the...
In January 2020, the FDA issued a strong warning about constipation on clozapine. With a fatality rate of 1 in 1000, this is not just a nuisance side effect, and it can happen with other antipsychotics and psychotropics as well....